FDA Home Page | CDER Home Page | CDER Site Info | Contact CDER | What's New @ CDER
General Comments on the Development of the Guidance Documents
Goals of Process
Intent of the Guidance Documents
Analysis Issues
Analysis of Active Control Trials
Populations to be Analyzed
Download presentation source
Last update: July 8, 2005
CDER Home Page | CDER Site Info | Contact CDER | What's New @ CDER FDA Home Page | Search FDA Site | FDA A-Z Index | Contact FDA | Privacy | Accessibility | HHS Home Page
FDA/Center for Drug Evaluation and Research